We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$335M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$140M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$82.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.4M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UWMC icon
3951
UWM Holdings
UWMC
$2.61B
$11.6K ﹤0.01%
2,079
-1,893
-48% -$10.2K
TAST
3952
DELISTED
Carrols Restaurant Group, Inc.
TAST
$11.6K ﹤0.01%
2,310
-4,039
-64% -$18.3K
ELYS
3953
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$11.6K ﹤0.01%
30,525
+17,025
+126% +$8.38K
BRZU icon
3954
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.2M
$11.6K ﹤0.01%
130
-121
-48% -$9.05K
ACGN
3955
DELISTED
Aceragen Inc
ACGN
$11.6K ﹤0.01%
7,126
+971
+16% +$1.8K
OMGA
3956
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$11.6K ﹤0.01%
2,074
-10,089
-83% -$78.9K
CUEN
3957
DELISTED
Cuentas Inc. Common Stock
CUEN
$11.6K ﹤0.01%
2,713
+458
+20% +$2.21K
LVOX
3958
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$11.6K ﹤0.01%
4,222
+910
+27% +$2.54K
AOMR
3959
Angel Oak Mortgage REIT
AOMR
$209M
$11.6K ﹤0.01%
1,408
-235
-14% -$1.81K
XERS icon
3960
Xeris Biopharma Holdings
XERS
$1.52B
$11.6K ﹤0.01%
4,427
-4,534
-51% -$11.5K
GIPR icon
3961
Generation Income Properties
GIPR
$727K
$11.6K ﹤0.01%
291
+59
+25% +$2.49K
FAZE
3962
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$11.5K ﹤0.01%
23,425
+2,194
+10% +$1.11K
HYFM icon
3963
Hydrofarm Holdings
HYFM
$8.58M
$11.5K ﹤0.01%
1,476
+821
+125% +$9.81K
DTST icon
3964
Data Storage Corp
DTST
$8.37M
$11.5K ﹤0.01%
4,953
-857
-15% -$1.65K
NCRA icon
3965
Nocera
NCRA
$3.7M
$11.5K ﹤0.01%
154
-87
-36% -$3.77K
XLO icon
3966
Xilio Therapeutics
XLO
$59.3M
$11.5K ﹤0.01%
314
-14
-4% -$596
RGLS
3967
DELISTED
Regulus Therapeutics
RGLS
$11.5K ﹤0.01%
7,829
-4,002
-34% -$5.33K
CCLD icon
3968
CareCloud
CCLD
$104M
$11.5K ﹤0.01%
3,897
+274
+8% +$868
WNEB icon
3969
Western New England Bancorp
WNEB
$282M
$11.5K ﹤0.01%
1,968
+1,188
+152% +$7.71K
AYTU icon
3970
AYTU BioPharma
AYTU
$24.7M
$11.5K ﹤0.01%
7,172
+5,446
+316% +$10.7K
AFIB
3971
DELISTED
Acutus Medical Inc
AFIB
$11.5K ﹤0.01%
12,912
+5,140
+66% +$4.36K
LAB icon
3972
Standard BioTools
LAB
$294M
$11.5K ﹤0.01%
5,939
-295
-5% -$582
NERV icon
3973
Minerva Neurosciences
NERV
$187M
$11.5K ﹤0.01%
1,254
+432
+53% +$2.28K
IMDX
3974
Insight Molecular Diagnostics
IMDX
$121M
$11.5K ﹤0.01%
2,490
+578
+30% +$2.91K
OVID icon
3975
Ovid Therapeutics
OVID
$523M
$11.4K ﹤0.01%
3,488
-1,822
-34% -$6.19K
157 158
159
160 161

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.